v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 36,294 $ 85,452
Accounts receivable, net 241,544 134,617
Inventory, net 111,873 53,434
Other current assets and prepaid expenses 38,398 50,542
Total current assets 428,109 324,045
Property, plant and equipment, net 134,102 127,111
Intangible assets, net 486,418 528,962
In-process research and development 590,200 590,200
Goodwill 675,795 671,940
Investments 14,325 20,746
Operating lease right-of-use assets 36,485 39,380
Other assets 5,857 6,888
Total assets 2,371,291 2,309,272
Current liabilities:    
Accounts payable 65,685 62,537
Accrued expenses 248,422 164,925
Current maturities of operating leases 9,080 12,038
Current portion of lines of credit and notes payable 12,702 9,619
Total current liabilities 335,889 249,119
Operating lease liabilities 28,225 27,665
Convertible notes 219,194 211,208
Deferred tax liabilities, net 119,182 118,717
Other long-term liabilities, principally contract liabilities, contingent consideration and line of credit 45,031 87,804
Total long-term liabilities 411,632 445,394
Total liabilities 747,521 694,513
Equity:    
Common Stock - $0.01 par value, 1,000,000,000 shares authorized; 670,550,201 and 670,378,701 shares issued at September 30, 2020 and December 31, 2019, respectively 6,706 6,704
Treasury Stock - 549,907 shares at September 30, 2020 and December 31, 2019, respectively (1,791) (1,791)
Additional paid-in capital 3,150,437 3,142,993
Accumulated other comprehensive loss (17,451) (22,070)
Accumulated deficit (1,514,131) (1,511,077)
Total shareholders’ equity 1,623,770 1,614,759
Total liabilities and equity $ 2,371,291 $ 2,309,272

Source